+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Endothelial Proliferative Activity in Serum of Diabetics with Retinopathy is Not Related to Serum Growth Hormone (GH) or Insulin-Like Growth Factor I (IGF-I) Concentration



Endothelial Proliferative Activity in Serum of Diabetics with Retinopathy is Not Related to Serum Growth Hormone (GH) or Insulin-Like Growth Factor I (IGF-I) Concentration



Clinical Science 76(S20): 51p.2-51p




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062039264

Download citation: RISBibTeXText

DOI: 10.1042/cs076051pa


Related references

The Effect Of Carbohydrate Restriction On Glucose Tolerance, Serum Insulin-Like Activity And Growth Hormone-Dependent Sulphation Factor In The Serum Of Diabetics. Acta Medica Scandinavica 174: 769-775, 1963

The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clinical Endocrinology 32(2): 229-239, 1990

Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy. Ophthalmic Research 37(4): 188-190, 2005

Association of single nucleotide polymorphisms in the growth hormone and growth hormone receptor genes with blood serum insulin-like growth factor I concentration and growth traits in Angus cattle1,2,3. Journal of Animal Science 81(3): 641-648, 2003

Association of single nucleotide polymorphisms in the growth hormone and growth hormone receptor genes with blood serum insulin-like growth factor I concentration and growth traits in Angus cattle. Journal of Animal Science 81(3): 641-648, 2003

Serum growth hormone , insulin like growth factor one and insulin like growth factor binding protein three in diabetic retinopathy. Diabetes 48(Suppl. 1): A386, 1999

Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema. Acta Ophthalmologica 89(3): 248-254, 2011

Serum erythropoietin, insulin-like growth factor 1, and vascular endothelial growth factor in etiopathogenesis of retinopathy of prematurity. Ophthalmic Surgery Lasers and Imaging Retina 44(6): 549-554, 2013

Correlation of serum insulin like growth factor-I with retinopathy in Malaysian pregnant diabetics. International Journal of Ophthalmology 4(1): 69-72, 2011

Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity. Acta Endocrinologica 128(2): 144-149, 1993

Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo. Febs (federation Of European Biochemical Societies) Letters. 334(1): 23-26, 1993

Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activity. Diabetes Care 27(1): 287-288, 2004

Hepatocyte Growth Factor in the Vitreous Fluid of Patients With Proliferative Diabetic Retinopathy: Its relationship with vascular endothelial growth factor and retinopathy activity. Diabetes Care 27(1): 287-288, 2004

Preferential measurement of insulin like growth factor i related peptides in serum with the aid of insulin like growth factor binding proteins produced by rat liver in culture estimation of serum insulin like growth factor binding protein levels. Journal of Clinical Endocrinology & Metabolism 59(3): 453-462, 1984

Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion. Clinical Endocrinology 42(4): 425-430, 1995